Azoji becomes Neimeth MD/CEO
14 March 2019 | 4:49 am
The Board of Neimeth International Pharmaceuticals Plc has appointed Matthew Azoji as the new managing director/Chief Executive Officer of the company.
TransNational Corporation appreciated by 10.10 per cent to close at N6.87 per share. Linkage Assurance garnered 7.02 per cent to close at N0.61 per share. Julius Berger also added 4.98 per cent to close at N41.52 per share.<br />
The appointment was ratified by the shareholders during the 60th yearly meeting of the company in Lagos. Azoji graduated from the Obafemi Awolowo University, Ile-Ife, Osun State, where he obtained his B. Pharm (First Class Honours). He obtained an MBA (Marketing) from the Enugu State University of Science and Technology, Enugu, and an Advanced Management Programme (AMP) from the Lagos Business School; Pan Atlantic University, Lagos.
In a statement signed by Director of Administration, Neimeth International Pharmaceuticals Plc, Isaac Igbanoi, Azoji is expected to drive the activities of the company towards a greater future with his wealth of experience in the Pharmaceutical Industry.
He obtained certificates in Pharmaceutical Policy and Pharmacoeconomics from Utrecht University in the Netherlands (a World Health Organisation (WHO) collaborating centre), and went on to get his M.Sc. in Public health from the University of London, International Programmes.
He has an M.Phil (Pharmacy Administration) from Obafemi Awolowo University, Ile-Ife. Azoji is currently a Fellow of Pharmaceutical Society of Nigeria (FPSN) and fellow, West African Postgraduate College of Pharmacists (FPCPharm). Matthew Obi Azoji had before now worked with May & Baker at various levels; was the pioneer MD/CEO of CHAN Medi-Pharm Ltd/Gte, and led the executive and management teams of Biovaccines Nigeria Ltd., a public private partnership company between the Federal Government of Nigeria and May & Baker Nigeria Ltd., from where he joined Neimeth.
He is reputed to be a performance driven professional with over 20 years experience at senior level as a leader in the pharmaceutical and public health sectors of Nigeria.
Matthew Azoji
Neimeth International Pharmaceuticals Plc
Foundation launches Ohuanbunwa's new books today
IN a renewed effort to tackle Nigeria's nagging challenges of nationhood, The Sam Ohuanbunwa Foundation For Economic Empowerment (SOFEE) has launched two new books and reissued three earlier titles to mark the 65th birthday of its founder, pharmacist, industrialist and author, Mazi Sam Ohuanbunwa.
Firms' restructuring bolsters demand for equities
PRESSURE by investors to garner the low-priced stocks has further been bolstered by the recent boards' restructuring and changes in ownership in some quoted firms.
Call for nominations for Nigerian Healthcare Excellence Award
The Nigerian Healthcare Excellence Award (NHEA) has called for nominations for the fifth edition of the Oscar of Nigeria healthcare award.
Biovaccines Nigeria appoints Azoji as COO
Matthew Azoji has been appointed Chief Operating Officer/ Executive Director of Biovaccines Nigeria Limited.Until his appointment, Azoji was the Managing Director and chief executive of CHAN Medi-Pharm Ltd/Gte Jos, Plateau State.
Who should be held responsible for drug misuse, abuse in Nigeria?
In the year 2001 or thereabout, I was a member of a delegation of the Nigerian American Chamber of Commerce (NACC) that visited President Olusegun Obasanjo at Aso Rock. The delegation was led by the President of the chamber at that time, Chief (Mrs) Priscillia Kuye (SAN).
Increasing reliance on local drugs
The newly elected President of the Pharmaceutical Society of Nigeria (PSN), Mazi Sam Ohuabunwa, has pledged among other things to ensure that the increased reliance on local production of drugs as enshrined in the national health and drug policies are pursued determinedly to help promote national security and create more jobs for pharmacists in the…